
~5 years of efficacy & safety data for DARZALEX® + Rd in newly diagnosed, transplant-ineligible patients1,2

The science behind DARZALEX FASPRO® and DARZALEX®

Administering DARZALEX FASPRO®
and DARZALEX®
Resources for your practice to help your patients
Tap into education and guidance to support you and your patients along the treatment journey
DARZALEX FASPRO® doctor conversation guide
Assists patients with preparing questions for their doctor about DARZALEX FASPRO®
DARZALEX® personalized doctor conversation starter
Allows patients to choose questions about DARZALEX® to discuss with their doctor
Patient education and support program
Provides one-on-one guidance, information, and education to help patients start and stay on treatment
Patient support organizations
Provide education, resources, and research for patients with multiple myeloma
DARZALEX FASPRO® MOA video
Explains the science behind daratumumab and hyaluronidase, the active ingredients in DARZALEX FASPRO®
Dosing and administration guide
Provides step-by-step instructions on how to administer DARZALEX FASPRO® and DARZALEX®
DRd=DARZALEX® (D) + lenalidomide (R) + dexamethasone (d); MOA=mechanism of action; Rd=lenalidomide (R) + dexamethasone (d).